By Mill Chart
Last update: Jun 3, 2025
BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) has been identified as a high-growth momentum stock that aligns with Mark Minervini’s Trend Template. The company, a biotechnology firm specializing in treatments for rare diseases, demonstrates strong technical and fundamental characteristics that make it a compelling candidate for growth-focused investors.
BCRX satisfies the key technical criteria outlined in Minervini’s strategy, which focuses on stocks in strong uptrends:
These factors indicate a stock in a sustained uptrend with strong momentum—a hallmark of Minervini’s high-probability setups.
Beyond technicals, BCRX exhibits accelerating growth metrics that appeal to high-growth investors:
BCRX holds a perfect 10/10 technical rating from ChartMill, reflecting its strong trend and market leadership. Key takeaways from the report:
For a deeper analysis, review the full technical report here.
Our High Growth Momentum + Trend Template screener identifies more stocks with similar growth and technical strength.
This is not investment advice. Always conduct your own research and consider risk tolerance before making investment decisions.
10.73
-0.02 (-0.19%)
Find more stocks in the Stock Screener
BIOCRYST PHARMACEUTICALS (NASDAQ:BCRX) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.